SR121463B

DRUG3 trials

Sponsors

Sanofi

Conditions

Congestive Heart FailureHyponatremiaInappropriate ADH Syndrome

Phase 3

Efficacy and Safety of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion

CompletedNCT00264927

SanofiHyponatremia, Inappropriate ADH Syndrome

Start: 2004-05-31End: 2007-09-30Updated: 2008-12-10

Safety and Efficacy of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion

CompletedNCT00264914

SanofiHyponatremia, Inappropriate ADH Syndrome

Start: 2005-07-31End: 2007-08-31Updated: 2009-01-21

DILIPO (DILutIonal HyPOnatremia)

CompletedNCT00274326

SanofiCongestive Heart Failure

Start: 2005-05-31End: 2007-07-31Target: 150Updated: 2008-09-15

Related Papers

Short- and long-term treatment of dilutional hyponatraemia with satavaptan, a selective arginine vasopressin V2-receptor antagonist: the DILIPO study.

2011-01-0327 citations